Bio-Matrix Scientific Signs Lease on 15,000 sq. ft. Building for Its Stem Cell Research Facility and Stem Cell Bank.

SAN DIEGO -- Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) announced today that it has signed a five year lease on a 15,000 sq ft building, formerly the American Red Cross Blood Testing facility in San Diego. The Company plans to build-out 3 Stem Cell Research Laboratories and a Stem Cell Bank designed to house adult stem cells derived from adipose tissue over the course of the next 3 months.

Chairman David Koos stated, "We intend to build a state-of-the-art research facility and stem cell bank. We are currently in discussions with several potential companies that could lead to potential joint ventures with us, using our new facility to conduct stem cell research in conjunction with our staff once the building's improvements have been completed."

Dr. Geoffrey O'Neill, President of Bio-Matrix stated, "Bio-Matrix' stem cell processing and cryo-storage laboratories will be a state-of-the-art, good manufacturing practices (cGMP) and good tissue practices (cGTP) compliant. This facility will be aligned with the Food and Drug Administration (FDA) 21 CFR Part 1271, a new federal regulation effective May 2005.

"The Company anticipates the building will incorporate Class 100 and Class 10,000 environments for Bio-Matrix' core businesses, which include stem cell processing operations and a medical device division. Acquisition of these new laboratories and stem cell bank should provide Bio-Matrix with a substantial competitive edge in its quest to secure a leadership position in this industry."

"This building represents a significant opportunity for Bio-Matrix to expand its business into several dynamic areas. The Company's business model is rapidly unfolding and with the signing of this lease, we see the Company coming of age quickly," noted Brian Pockett, Managing Director.

The new 15,000 sq ft, state-of-the-art facility, located in the heart of San Diego's biotechnology community, will house Bio-Matrix' secure cryogenic adult stem cell bank, clean rooms for tissue processing and cellular analysis as well as various research laboratories. This facility will also house Bio-Matrix' medical device and instrumentation divisions as well as its marketing and corporate offices.

More information will be available shortly on the Company's website: www.BMXGonline.com.

About Bio-Matrix Scientific Group Inc.:

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are StemCells Inc. (Nasdaq:STEM) and Cryo-Cell International Inc. (OTCBB:CCEL).

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.